Cargando…
Slow on the Uptake, Progression to Heartbreak
The prevalence of serotonin syndrome increases over the past several years as more serotonergic medications are being used in clinical practice. It is a potentially lethal condition caused by excessive serotonergic activity. Common causes of serotonin syndrome are the use of prescription medications...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318803/ https://www.ncbi.nlm.nih.gov/pubmed/32583694 http://dx.doi.org/10.1177/2324709620936832 |
_version_ | 1783550933590867968 |
---|---|
author | Binder, Ashley K. Haydek, John P. Parihar, Siddhant Modlin, Chelsea E. Tannu, Manasi Aldredge, Amalia Sueblinvong, Viranuj |
author_facet | Binder, Ashley K. Haydek, John P. Parihar, Siddhant Modlin, Chelsea E. Tannu, Manasi Aldredge, Amalia Sueblinvong, Viranuj |
author_sort | Binder, Ashley K. |
collection | PubMed |
description | The prevalence of serotonin syndrome increases over the past several years as more serotonergic medications are being used in clinical practice. It is a potentially lethal condition caused by excessive serotonergic activity. Common causes of serotonin syndrome are the use of prescription medications, illicit drugs, or a combination of substances, leading to an increase in the activity of serotonin in the central and peripheral nervous system. The clinical symptoms range from mild to severe. We report a case of a 25-year-old woman with polysubstance abuse, including cocaine, who presented with confusion, rigidity, high-grade fever, and reduced biventricular function on echocardiogram. Based on the combination of substance used history, clinical presentation, and echocardiogram findings, she was diagnosed with serotonin syndrome complicated by takotsubo cardiomyopathy. She improved after being treated in the intensive care unit and was discharged from the hospital. This patient demonstrates the importance of recognizing and promptly initiating management of serotonin syndrome in order to improve morbidity and mortality. |
format | Online Article Text |
id | pubmed-7318803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-73188032020-07-06 Slow on the Uptake, Progression to Heartbreak Binder, Ashley K. Haydek, John P. Parihar, Siddhant Modlin, Chelsea E. Tannu, Manasi Aldredge, Amalia Sueblinvong, Viranuj J Investig Med High Impact Case Rep Case Report The prevalence of serotonin syndrome increases over the past several years as more serotonergic medications are being used in clinical practice. It is a potentially lethal condition caused by excessive serotonergic activity. Common causes of serotonin syndrome are the use of prescription medications, illicit drugs, or a combination of substances, leading to an increase in the activity of serotonin in the central and peripheral nervous system. The clinical symptoms range from mild to severe. We report a case of a 25-year-old woman with polysubstance abuse, including cocaine, who presented with confusion, rigidity, high-grade fever, and reduced biventricular function on echocardiogram. Based on the combination of substance used history, clinical presentation, and echocardiogram findings, she was diagnosed with serotonin syndrome complicated by takotsubo cardiomyopathy. She improved after being treated in the intensive care unit and was discharged from the hospital. This patient demonstrates the importance of recognizing and promptly initiating management of serotonin syndrome in order to improve morbidity and mortality. SAGE Publications 2020-06-25 /pmc/articles/PMC7318803/ /pubmed/32583694 http://dx.doi.org/10.1177/2324709620936832 Text en © 2020 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Binder, Ashley K. Haydek, John P. Parihar, Siddhant Modlin, Chelsea E. Tannu, Manasi Aldredge, Amalia Sueblinvong, Viranuj Slow on the Uptake, Progression to Heartbreak |
title | Slow on the Uptake, Progression to Heartbreak |
title_full | Slow on the Uptake, Progression to Heartbreak |
title_fullStr | Slow on the Uptake, Progression to Heartbreak |
title_full_unstemmed | Slow on the Uptake, Progression to Heartbreak |
title_short | Slow on the Uptake, Progression to Heartbreak |
title_sort | slow on the uptake, progression to heartbreak |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318803/ https://www.ncbi.nlm.nih.gov/pubmed/32583694 http://dx.doi.org/10.1177/2324709620936832 |
work_keys_str_mv | AT binderashleyk slowontheuptakeprogressiontoheartbreak AT haydekjohnp slowontheuptakeprogressiontoheartbreak AT pariharsiddhant slowontheuptakeprogressiontoheartbreak AT modlinchelseae slowontheuptakeprogressiontoheartbreak AT tannumanasi slowontheuptakeprogressiontoheartbreak AT aldredgeamalia slowontheuptakeprogressiontoheartbreak AT sueblinvongviranuj slowontheuptakeprogressiontoheartbreak |